Cisapride

DRUG4 trials

Sponsors

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Conditions

Diabetes MellitusGastroesophageal RefluxGastroparesisInfant, NewbornInfant, Premature

Phase 4

An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment Options

TerminatedNCT01281540

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Gastroparesis

Start: 2003-05-31End: 2003-11-30Updated: 2011-01-24

A Study of Cisapride in Premature Infants With Feeding Problems

TerminatedNCT01281566

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Infant, Newborn, Infant, Premature

Start: 2003-03-31End: 2003-07-31Updated: 2011-01-24

A Study of Cisapride in Patients With Symptomatic Gastro-Oesophageal Reflux Disease

TerminatedNCT01281553

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Gastroesophageal Reflux

Start: 2003-09-30End: 2003-10-31Updated: 2011-01-24

An Efficacy and Safety Study of Cisapride for Improving Symptoms Associated With Gastroparesis in Patients With Diabetes Mellitus

TerminatedNCT01286090

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Diabetes Mellitus, Gastroparesis

Start: 2003-07-31End: 2003-10-31Updated: 2011-01-31

Related Papers

How many unpublished studies? ClinicalTrials.gov (n = 2614 studies): diabetes | Closed Studies | Interventional Studies | Phase 3, 4 | Search Date: Oct 27, 2014

Figshare2014-01-01